Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06715865

Clinical Study on Thymus-Kidney Transplantation From Neonatal Donors for the Induction of Immune Tolerance

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
10 (estimated)
Sponsor
RenJi Hospital · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Thymus transplantation for the induction of immune tolerance in kidney transplantation: This study aims to understand how thymus transplantation can induce immune tolerance in recipients of allogeneic kidney transplants to achieve the discontinuation of immunosuppressive therapy. It will evaluate the safety of thymus transplantation, explore the functional output of thymus tissue, investigate the optimal timing for withdrawal of immunosuppressants, and identify key indicators for the reconstruction of immune suppression capacity.

Conditions

Interventions

TypeNameDescription
PROCEDUREThymus TransplantationThymus Transplantation

Timeline

Start date
2025-01-01
Primary completion
2027-12-01
Completion
2027-12-01
First posted
2024-12-04
Last updated
2024-12-04

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06715865. Inclusion in this directory is not an endorsement.

Clinical Study on Thymus-Kidney Transplantation From Neonatal Donors for the Induction of Immune Tolerance (NCT06715865) · Clinical Trials Directory